Our funding programs support early stage, Ohio-based companies to achieve success.
Develop
Attract
Incubate
Accelerate
Evaluate
Cell Targeting, Inc. is a preclinical-stage company developing a drug delivery platform utilizing a tissue-specific peptide targeting technology with broad therapeutic potential, including delivery of cardiovascular cellular therapies. In January 2011 the company technology was acquired by BioTime, Inc.
view all portfolio clientsGlobal Cardiovascular Innovation Center
The Global Cardiovascular Innovation Center acknowledges the contribution of the State of Ohio Department of Development and the Ohio Third Frontier Program which provided funding and support.
